Interacting Drugs |
Moclobemide vs Alpha-/Beta-Agonists (Direct-Acting) |
Security Level |
|
Mechanism |
Alpha-/Beta-Agonists (Direct-Acting): MAO Inhibitors may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting). Primarily with oral administration of phenylephrine. Exceptions: Dipivefrin. |
Management |
Consider therapy modification |
Moclobemide vs Alpha-/Beta-Agonists (Direct-Acting)
Post Review about Moclobemide vs Alpha-/Beta-Agonists (Direct-Acting) Click here to cancel reply.
Other Interactions of Alpha-/Beta-Agonists (Direct-Acting)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.